Product
SPIROMAX
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A 12-Week Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX(R) 160/4.5 mcg Inhalation Powder Versus SYMBICORT(R) TURBOHALER(R) 200/6 mcg in Adult and Adolescent Patients With Persistent AsthmaStatus: Completed, Estimated PCD: 2014-03-20